| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.58B | 14.52B | 14.35B | 14.69B | 14.78B | 14.74B |
| Gross Profit | 3.63B | 3.56B | 3.39B | 3.25B | 3.41B | 3.51B |
| EBITDA | 1.45B | 1.38B | 1.36B | 1.16B | 1.33B | 1.28B |
| Net Income | 743.00M | 696.00M | 717.00M | 487.00M | 657.00M | 776.00M |
Balance Sheet | ||||||
| Total Assets | 9.56B | 10.01B | 10.08B | 9.77B | 9.81B | 9.36B |
| Cash, Cash Equivalents and Short-Term Investments | 5.79B | 5.62B | 5.58B | 3.91B | 4.32B | 3.93B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.58B | 2.68B | 2.78B | 2.86B | 2.81B | 2.71B |
| Stockholders Equity | 6.98B | 7.33B | 7.30B | 6.90B | 7.00B | 6.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 952.00M | 2.15B | 503.00M | 1.08B | 436.00M |
| Operating Cash Flow | 0.00 | 972.00M | 2.17B | 515.00M | 1.11B | 494.00M |
| Investing Cash Flow | 0.00 | -278.00M | -172.00M | -350.00M | -389.00M | -399.00M |
| Financing Cash Flow | 0.00 | -656.00M | -329.00M | -571.00M | -330.00M | -296.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥8.05B | 18.46 | ― | ― | 28.63% | 551.37% | |
76 Outperform | ¥9.45B | 14.61 | ― | 4.24% | 2.08% | 25.42% | |
66 Neutral | ¥10.53B | 12.59 | ― | 2.45% | 9.77% | 93.99% | |
65 Neutral | ¥9.78B | 25.64 | ― | 1.51% | 8.65% | 12.86% | |
65 Neutral | ¥9.15B | 7.53 | ― | 1.20% | 12.21% | 6.86% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | ¥10.41B | -9.40 | ― | ― | 14.25% | ― |